Home Sectors Healthcare Recent Movement: Phibro Animal Health Corporation (NASDAQ: PAHC)

Recent Movement: Phibro Animal Health Corporation (NASDAQ: PAHC)


Phibro Animal Health Corporation trades as part of the drug manufacturers industry and trades as part of the healthcare sector. Phibro Animal Health Corp is a diversified animal health and mineral nutrition company. It develops, manufactures and markets products for food animals including poultry, swine and cattle.

Previous Intraday Trading Performance:

The PAHC stock showed a previous change of -0.75% with an open at 29.49 and a close of 29.18. It reached an intraday high of 29.60 and a low of 28.97.

SeekingAlpha:  Barclays bearish on Teva, sees 14% downside risk in premarket analyst action


The stock has a market cap of $1.2b with 40.5m shares outstanding, of which the float is 40.4m shares. Trading volume reached 95,814 shares compared to its average volume of 238,748 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, Phibro Animal Health Corporation shares returned -2.60% and in the past 30 trading days it returned -17.59%. Over three months, it changed -0.88%. In one year it has changed -36.77% and within that year its 52-week high was 54.62 and its 52-week low was 27.32. PAHC stock is 6.83% above its 52 Week Low.

Our calculations show a 200 day moving average of 34.89 and a 50 day moving average of 31.41. Currently PAHC stock is trading -16.36% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.

SeekingAlpha:  Barclays bearish on Teva, sees 14% downside risk in premarket analyst action


The last annual fiscal EPS for the company was reported at 1.6 that ended on 30th of June 2018, which according to the previous close, that is a PE of 18.24. Based on 2 analyst estimates, the consensus EPS for the next quarter is 0.42. The TTM EPS is 1.75, which comes to a TTM PE of 16.67.

Below was the last reported quarterly diluted earnings per share:

1stQtr of 2019 (Reported on 05/06/2019): 0.37
4thQtr of 2018 (Reported on 02/06/2019): 0.36
3rdQtr of 2018 (Reported on 11/06/2018): 0.40
2ndQtr of 2018 (Reported on 08/27/2018): 0.55
1stQtr of 2018 (Reported on 05/07/2018): 0.49

The dividend per share is currently 0.48, which is a dividend yield of 1.64%. Also, the payout ratio is 27.43%, therefore the dividend is safe according to our calculations.

Base on our calculations, the intrinsic value per share is 48.58, which means it is possibly undervalued and has a margin of safety of 39.93%.

Indicators to Watch:

Based on the latest filings, there is 88.70% of institutional ownership.

The current calculated beta is 0.68.

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 35.55%, return on assets is 10.33%, profit margin is 8.39%, price-to-sales is 1.42 and price-to-book is 5.56.

Company Scores:

All scores are out of six:
 3  :Valuation Score
 2  :Past Performance Score
 4  :Financial Strength Score
 1  :Future Growth Score
 3  :Dividend Score
 2  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.